RemedyRepack Inc. recalls Carvedilol 25 mg Tablet
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
- Products
-
- Carvedilol 25 mg Tablet
- Company
- RemedyRepack Inc.
- Where it was sold
-
FL
States: Florida
- Units affected
- 247 blister packs
- About this recall
- Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.